In summary, our study shows that VEGF189, but not two other major isoforms of VEGF, is selectively enriched in cancer cell-derived sEVs, associates with the surface of sEVs via heparin-binding, and can be delivered in signaling-competent form by sEVs to endothelial cells independently of EV uptake. This evidence concerns the gene VEGFA and cancer.